| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1350 | Cg-707 | Novel PRL-3 inhibitor, blocking the migration and invasion of metastatic cancer cells |
|
| DCC1351 | Cga-jk3 Featured | CGA-JK3 is CGA-JK3 is an ATP-competitive inhibitor of IKKβ-catalyzed kinase activity. CGA-JK3 inhibits IκBα phosphorylation in LPS (HY-D1056) - induced RAW 264.7 cells. |
|
| DCC1352 | C-gboxin | Novel functional Gboxin analogue that is suitable for live-cell ultraviolet crosslink conjugation and click chemistry |
|
| DCC1353 | Cgi-560 | Novel Bruton's tyrosine kinase (BTK) inhibitor |
|
| DCC1354 | Cgk062 | Novel inhibitor of Wnt/β-catenin signaling; Anticancer agent promoting PKCα-mediated β-catenin phosphorylation/degradation |
|
| DCC1355 | Cgp-49823 | Non-peptide tachykinin NK1 receptor antagonist |
|
| DCC1356 | Cgp52608 | Activator of RORalpha, inducing growth arrest in androgen-independent DU 145 prostate cancer cells |
|
| DCC1357 | Cgp-53437 | Novel HIV-1 protease inhibitor, also potently inhibiting major aspartyl peptidase 1 (May1), a secreted Cryptococcus neoformans protease |
|
| DCC1358 | Cgp64222 | Peptoid Tat/transactivation response element inhibitor, inhibiting human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry |
|
| DCC1359 | cgs-23425 | Liver specific thyromimetic agonist of thyroid hormone receptor- |
|
| DCC1360 | cgs-25966 | Broad spectrum matrix metalloproteinase (MMP) inhibitor |
|
| DCC1361 | Cycluc3 | Mutant firefly luciferase variant with enhanced light emission |
|
| DCC1362 | Cgs27023a | Matrix metalloproteinase (MMP) inhibitor |
|
| DCC1363 | Cycluc3 Sodium Salt | Water soluble CycLuc3, mutant firefly luciferase variant with enhanced light emission |
|
| DCC1364 | Cgs-8612 | Benzodiazepine antagonist |
|
| DCC1365 | cgs-9896 | Benzodiazepine receptor partial agonist |
|
| DCC1366 | Ch1055 | The first small-molecule based MCM2-targeted NIR-II probe |
|
| DCC1367 | Ch24h Inhibitor 17 | Novel Highly Potent and Selective Cholesterol 24-Hydroxylase (CH24H) Inhibitor |
|
| DCC1368 | Ch-3-8 | Novel microtubule polymerization inhibitor with little susceptible to transporter-mediated chemoresistance |
|
| DCC1369 | Ch5015765 | Novel Hsp90 inhibitor |
|
| DCC1370 | Ch-5137291 | Potent Androgen_receptor>androgen receptor (AR) pure antagonist which did not produce the agonist metabolite |
|
| DCC1371 | Ch5138303 | Novel Hsp90 inhibitor |
|
| DCC1372 | Chalkophomycin | Novel inhibitor of mitochondrial respiration, targeting drug-resistant cancer cells with stem-like features by inhibiting mitochondrial respiration complex I (NADH:ubiquinone oxidoreductase, complex I [CI]) |
|
| DCC1373 | Chdi-180-oh | The desmethyl precursor of CHDI-180R which is a first-in-class high-affinity PET imaging ligand specific for mHTT aggregates |
|
| DCC1374 | Chdi-340246 | Novel potent and selective kynurenine mono-oxygenase (KMO) inhibitor |
|
| DCC1375 | Chelator 1a | Novel intracellular chelator, disrupting iron homeostasis in bacteria |
|
| DCC1376 | Chembl1784973 | Novel inhibitor against Lactate Dehydrogenase (LDH) of Cryptosporidium parvum |
|
| DCC1377 | Chembl94431 | Inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase |
|
| DCC1378 | Chemr23 Inhibitor 14f | Novel potent and orally active ChemR23 inhibitor (IC 80 = 12 nM), showing a long-acting effect in cynomolgus monkeys |
|
| DCC1379 | Ches/aß-in-9q | Novel dual inhibitor of cholinergic dysfunction and amyloid deposition for AD treatment, penetrating the blood-brain barrier (BBB) and enhancing the cerebral acetylcholine level |
|
